Phenotypic and genotypic profiling of MDM2, respective to the TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program Meeting Abstract
| Authors: | Xu-Monette, Z. Y.; Moller, M. B.; Tzankov, A.; Montes-Moreno, S.; Hu, W. W.; Manyam, G. C.; Kristensen, L.; Fan, L.; Visco, C.; Dybkaer, K.; Chiu, A.; Tam, W.; Zu, Y. L.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W. W. L.; van Krieken, J. H.; Huang, Q.; Huh, J.; Ai, W. Y.; Ponzoni, M.; Ferreri, A. J. M.; Wu, L.; Zhao, X. Y.; Bueso-Ramos, C. E.; Wang, S. A.; Go, R. S.; Li, Y.; Winter, J. N.; Piris, M. A.; Medeiros, L. J.; Young, K. H. |
| Abstract Title: | Phenotypic and genotypic profiling of MDM2, respective to the TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program |
| Meeting Title: | 2013 SOHO Annual Meeting |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 14 |
| Issue: | Suppl. |
| Meeting Dates: | 2013 Sep 18-21 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-09-01 |
| Start Page: | S146 |
| End Page: | S147 |
| Language: | English |
| ACCESSION: | WOS:000346949500072 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2014.06.085 |
| Notes: | Meeting Abstract: 510 -- Source: Wos |
